Loading insider details...
Beta
Latest Form 4 (Jul 7, 2026): Exercise/Conversion of 35,064 IBRX shares, $104.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 7, 2026 | ImmunityBio, Inc. (IBRX) | Exercise/Conversion | 35,064 | $104.5K |
| Jul 1, 2026 | ImmunityBio, Inc. (IBRX) | Exercise/Conversion | 32,173 | $95.9K |
| Jun 11, 2026 | ImmunityBio, Inc. (IBRX) | Grant/Award | 65,600 | n/a |
| Feb 25, 2026 | ImmunityBio, Inc. (IBRX) | Exercise/Conversion | 25,000 | $74.5K |
| Jan 22, 2026 | ImmunityBio, Inc. (IBRX) | Exercise/Conversion | 50,000 | $149.0K |
| Jun 20, 2025 | ImmunityBio, Inc. (IBRX) | Grant/Award | 162,786 | n/a |
| Jun 13, 2024 | ImmunityBio, Inc. (IBRX) | Grant/Award | 77,633 | n/a |
| Jun 15, 2023 | ImmunityBio, Inc. (IBRX) | Grant/Award | 158,263 | n/a |
| Jun 15, 2022 | ImmunityBio, Inc. (IBRX) | Grant/Award | 167,937 | n/a |
| Jun 14, 2021 | ImmunityBio, Inc. (IBRX) | Grant/Award | 26,064 | n/a |